Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 9, Issue 10
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Clinical/translational cancer immunotherapy
Original research
Risks and benefits of reinduction ipilimumab/nivolumab in melanoma patients previously treated with ipilimumab/nivolumab
Online download statistics by month:
Online download statistics by month: October 2021 to February 2024
Abstract
Full
Pdf
Oct 2021
420
425
87
Nov 2021
298
299
101
Dec 2021
169
169
38
Jan 2022
131
135
54
Feb 2022
138
142
58
Mar 2022
219
225
38
Apr 2022
239
243
45
May 2022
250
251
51
Jun 2022
253
253
58
Jul 2022
288
291
70
Aug 2022
331
336
34
Sep 2022
339
342
26
Oct 2022
270
278
27
Nov 2022
273
273
25
Dec 2022
237
239
20
Jan 2023
271
273
20
Feb 2023
311
312
21
Mar 2023
285
287
15
Apr 2023
203
203
29
May 2023
202
203
11
Jun 2023
237
239
20
Jul 2023
209
209
25
Aug 2023
213
214
24
Sep 2023
225
226
20
Oct 2023
194
195
20
Nov 2023
240
240
17
Dec 2023
199
199
32
Jan 2024
51
52
26
Feb 2024
136
136
22
Total
6831
6889
1034
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?